These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1474367)

  • 1. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction.
    Umstead GS; Neumann KH
    Arch Intern Med; 1986 May; 146(5):897-9. PubMed ID: 3963982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin ototoxicity.
    Thompson P; Wood RP; Bergstrom L
    J Otolaryngol; 1980 Feb; 9(1):60-2. PubMed ID: 7359612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ototoxic side effects in patients with ovarian cancer treated with cisplatin].
    Behling H; Spieske C; Krafft W
    Zentralbl Gynakol; 1988; 110(5):277-82. PubMed ID: 3376611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of cis-platinum ototoxicity.
    Moroso MJ; Blair RL
    J Otolaryngol; 1983 Dec; 12(6):365-9. PubMed ID: 6686617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity of cis-diamminedichloroplatinum.
    Vodvárka P; Foukalová J; Mrázek J; Philippová J
    Neoplasma; 1985; 32(2):229-38. PubMed ID: 4039797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin.
    Vasquez EM; Maddux MS; Sanchez J; Pollak R
    Arch Intern Med; 1993 Apr; 153(7):879-82. PubMed ID: 8466379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-platinum ototoxicity in children.
    Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
    Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from cisplatin-induced ototoxicity: a case report and review.
    Truong MT; Winzelberg J; Chang KW
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hearing loss after erythromycin therapy].
    Lind O; Harthug S
    Tidsskr Nor Laegeforen; 1993 Sep; 113(22):2810-1. PubMed ID: 8211901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin ototoxicity: a call to heighten recognition.
    Whitener CJ; Parker JE; Lapp NL
    South Med J; 1991 Oct; 84(10):1214-6. PubMed ID: 1925722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum.
    Koegel L
    Am J Otol; 1985 Mar; 6(2):190-9. PubMed ID: 3872601
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythromycin-induced ototoxicity substantiated by rechallenge.
    Schwartz JI; Maggini GA
    Clin Pharm; 1982; 1(4):374-6. PubMed ID: 7185536
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
    Beck E; Schuster M; Berg A; Jäger W; Wildt L; Lang N
    Gynakol Rundsch; 1991; 31 Suppl 2():280-5. PubMed ID: 1790954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reversible hearing loss and erythromycin].
    Rydberg J
    Lakartidningen; 1984 Mar; 81(13):1308. PubMed ID: 6708672
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.